Title of Presentation

The Ethics of Controlled Human Infection Trials in COVID-19 Research

Presenter Biography

The authors of this presentation are undergraduate or post bac students at Portland State University. The following presentation was a final for PHE 369- Public Health Law, Policy, and Ethics and highlights the ethical background and considerations behind controlled human infection trials, specifically in COVID-19 vaccine research.

Institution

PSU

Program/Major

Community Health Promotion

Degree

BS

Presentation Type

Poster

Start Date

8-4-2021 10:56 AM

End Date

8-4-2021 11:01 AM

Persistent Identifier

https://archives.pdx.edu/ds/psu/35579

Keywords

COVID-19, CHIs, Medical Ethics

Abstract

The use of CHIs to speed up COVID-19 vaccine research is something that has been approved by ethics committees in the UK. The purpose of this presentation is to break down the ethics behind these trials, weight the potential risks and benefits of them, and compare it to any prior research. Due to the uncertainty of how COVID-19 effects different people, the risks are hard to quantify, even in young, healthy individuals. Overall, without closer, more in depth research of this virus, understanding of its effects is unlikely. However, how much do you risk in order to achieve these benefits?

Share

COinS
 
Apr 8th, 10:56 AM Apr 8th, 11:01 AM

The Ethics of Controlled Human Infection Trials in COVID-19 Research

The use of CHIs to speed up COVID-19 vaccine research is something that has been approved by ethics committees in the UK. The purpose of this presentation is to break down the ethics behind these trials, weight the potential risks and benefits of them, and compare it to any prior research. Due to the uncertainty of how COVID-19 effects different people, the risks are hard to quantify, even in young, healthy individuals. Overall, without closer, more in depth research of this virus, understanding of its effects is unlikely. However, how much do you risk in order to achieve these benefits?